Theravance Bio: Q1 Earnings Snapshot

May 5, 2022 GMT

GEORGE TOWN, Cayman Islands (AP) _ Theravance Biopharma Inc. (TBPH) on Thursday reported a loss of $25.9 million in its first quarter.

The George Town, Cayman Islands-based company said it had a loss of 34 cents per share. Losses, adjusted for restructuring costs, were 24 cents per share.

The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 12 cents per share.

The biopharmaceutical company posted revenue of $13.2 million in the period.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on TBPH at